HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gillette

This article was originally published in The Rose Sheet

Executive Summary

Third quarter sales "may well be down somewhat" because of "broad-based weakness in international markets," the company said Sept. 17. Gillette stock price fell 10.7% to 40-3/16 by the close of trading Sept. 16 and was down an additional 3-5/16 to 36-7/8 on the day of the announcement. One-third of the company's sales in 1997, approximately $1.16 bil., were from overseas markets, excluding Western Europe. Despite weaknesses in Asia Pacific, Africa-Middle East, Eastern Europe and Latin America, Gillette said it is "optimistic" about long-term opportunities in these markets. The company noted the Mach3 shave system is not available in any of these markets and is currently being rolled out in Western Europe. Revlon and Colgate-Palmolive also suffered losses Sept 16 on concerns about the negative effect of international markets, closing down 1-13/16 to 34 and 1-11/16 to 72-1/2, respectively. Colgate was down 4 to 68-1/2, and Revlon dropped 2-1/16 to 31-15/16 on Sept. 17

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005827

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel